Hackensack Meridian Health
Clinical trials sponsored by Hackensack Meridian Health, explained in plain language.
-
Lyme disease trial withdrawn before it even started
Disease control TerminatedThis study aimed to test whether giving the antibiotic ceftriaxone every 5 days for about 6 weeks could kill the bacteria causing persistent Lyme disease symptoms. It planned to enroll people aged 18-75 with Post-Treatment Lyme Disease Syndrome. However, the trial was withdrawn b…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New cocktail targets tough lymphoma
Disease control OngoingThis early-phase study tests a combination of three drugs (ibrutinib, lenalidomide, and rituximab) in people with mantle cell lymphoma that has returned or not responded to prior treatment. The main goal is to find the safest dose of this combination by monitoring side effects. U…
Phase: PHASE1 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New cocktail of cancer drugs tested for Tough-to-Treat myeloma
Disease control OngoingThis study tests a combination of four drugs—carfilzomib, lenalidomide, vorinostat, and dexamethasone—in people with multiple myeloma that has relapsed or not responded to prior treatment. The goal is to find a safe dose and see if the combination helps control the cancer. Sevent…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo aims to tackle Hard-to-Treat multiple myeloma
Disease control TerminatedThis phase 2 study tests the drug selinexor combined with one of three other cancer drugs (carfilzomib, daratumumab, or pomalidomide) in 96 adults with multiple myeloma whose disease has worsened despite current treatment. Participants continue on the combination until the cancer…
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Withdrawn study sought to predict which legs could be saved
Diagnosis TerminatedThis study was designed to see if measuring blood flow resistance in tiny leg vessels could predict whether a limb could be saved after artery-opening procedures in people with critical limb ischemia. It planned to enroll patients with severe leg artery disease and use a special …
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Umbilical cord wrap may help men recover faster after prostate cancer surgery
Symptom relief OngoingThis study tests whether placing a cryopreserved umbilical cord allograft around nerves during robotic prostatectomy helps men regain erectile function and bladder control sooner. About 100 men with prostate cancer will be randomly assigned to receive either standard surgery or s…
Phase: PHASE2, PHASE3 • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New study asks: do all struggling newborns need breathing machines?
Symptom relief OngoingThis pilot study looks at whether full-term newborns with mild breathing problems can safely transition without a breathing tube called CPAP. Researchers will observe 22 babies born via scheduled C-section who show mild signs like flaring nostrils or light grunting. Half will rec…
Phase: EARLY_PHASE1 • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Home visitors test new way to support Parents' mental health
Knowledge-focused ENROLLING_BY_INVITATIONThis study explores how to add a mental health program called Mothers and Babies into existing home visiting services for pregnant people and new parents in Iowa and Indiana. Researchers will work with 1,750 home visitors and program recipients to see how well the program is adop…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC